Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc.verified

GLSI

Price:

$24.06

Market Cap:

$353.16M

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.

Industry

Biotechnology

IPO Date

2020-09-25

Stock Exchange

NASDAQ

Ticker

GLSI

The Current Ratio as of June 2026 (TTM) for Greenwich LifeSciences, Inc. (GLSI) is 2.01

According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.01. This represents a change of 58.92% compared to the average of 1.26 of the last 4 quarters.

Greenwich LifeSciences, Inc. (GLSI) Historical Current Ratio (quarterly & annually)

How has GLSI Current Ratio performed in the past?

The mean historical Current Ratio of Greenwich LifeSciences, Inc. over the last ten years is 19.40. The current 2.01 Current Ratio has changed 934.38% with respect to the historical average. Over the past ten years (40 quarters), GLSI's Current Ratio was at its highest in in the March 2022 quarter at 81.86. The Current Ratio was at its lowest in in the December 2025 quarter at -1.16.

Quarterly (TTM)
Annual

Average

19.40

Median

2.62

Minimum

-1.16

Maximum

70.63

Greenwich LifeSciences, Inc. (GLSI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Greenwich LifeSciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 552.21%

Maximum Annual Current Ratio = 70.63

Minimum Annual Increase = -144.10%

Minimum Annual Current Ratio = -1.16

Quarterly (TTM)
Annual
YearCurrent RatioChange
2025-1.16-144.10%
20242.62-88.95%
202323.74-53.66%
202251.23-27.47%
202170.63157.64%
202027.41552.21%
20190.00-95.75%
20180.12120.49%

Greenwich LifeSciences, Inc. (GLSI) Average Current Ratio

How has GLSI Current Ratio performed in the past?

The current Current Ratio of Greenwich LifeSciences, Inc. (GLSI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.40

5-year avg

29.41

10-year avg

19.40

Greenwich LifeSciences, Inc. (GLSI) Current Ratio vs. Peers

How is GLSI’s Current Ratio compared to its peers?

Greenwich LifeSciences, Inc.’s Current Ratio is less than Cognition Therapeutics, Inc. (5.92), less than Atossa Therapeutics, Inc. (4.92), greater than Tevogen Bio Holdings Inc. (0.29), greater than Oncolytics Biotech Inc. (1.38), less than Surrozen, Inc. (11.91), greater than TuHURA Biosciences, Inc. (1.15), less than Seer, Inc. (17.73), less than Opus Genetics, Inc. (7.13), greater than Agenus Inc. (0.38), less than Immix Biopharma, Inc. (8.76),

Build a custom stock screener for Greenwich LifeSciences, Inc. (GLSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Greenwich LifeSciences, Inc. (GLSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Greenwich LifeSciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for Greenwich LifeSciences, Inc. (GLSI)?

What is the highest Current Ratio for Greenwich LifeSciences, Inc. (GLSI)?

What is the 3-year average Current Ratio for Greenwich LifeSciences, Inc. (GLSI)?

What is the 5-year average Current Ratio for Greenwich LifeSciences, Inc. (GLSI)?

How does the current Current Ratio for Greenwich LifeSciences, Inc. (GLSI) compare to its historical average?